Laser-based therapies are being studied as a tool to reduce addiction cravings, but this technology is still experimental and far from a proven cure. The idea combines two separate lines of research: using focused light to influence brain activity related to addiction, and using artificial intelligence to improve how treatments are targeted. Neither has reached the point of widespread clinical use, but early results, particularly for opioid and stimulant cravings, are genuinely interesting.
How Lasers Interact With the Addicted Brain
Addiction reshapes the brain’s reward circuitry, particularly in the prefrontal cortex, the region responsible for impulse control and decision-making. In people with substance use disorders, this area becomes less active, making it harder to override compulsive drug-seeking behavior. The core idea behind laser-based addiction treatment is to reactivate that weakened circuitry.
The most dramatic demonstration came from a 2013 study at UC San Francisco, where researchers used a technique called optogenetics on rats. They inserted light-sensitive proteins into neurons in the prefrontal cortex, then activated those cells with a precisely tuned laser. Turning on the cells wiped out compulsive cocaine-seeking behavior entirely. Switching them off in non-addicted rats made those animals behave as if they were addicted. This proved a clear, causal link between prefrontal cortex activity and addictive behavior.
Optogenetics requires genetic modification of brain cells, so it can’t be used directly in humans. But the finding opened the door for non-invasive approaches that target the same brain region with light from outside the skull.
Transcranial Photobiomodulation for Opioid Cravings
The most promising human research involves transcranial photobiomodulation (tPBM), which delivers near-infrared light through the skull to stimulate brain tissue. Unlike optogenetics, it doesn’t require surgery or genetic engineering. The light penetrates a few centimeters into the brain and appears to boost cellular energy production in targeted areas, improving the function of underactive neurons.
A controlled trial on opioid cravings produced striking results. Participants who received active tPBM experienced a 51% decrease in craving scores one week after treatment, compared to just 15.8% in the placebo group. Over half of the active treatment group (53%) achieved at least a 60% reduction in cravings, versus only 18% in the placebo group. The effect size of 0.73 is considered moderate to large in clinical research, meaning the difference between real treatment and sham was substantial and unlikely due to chance.
Researchers also found that which side of the brain was treated mattered. Targeting the hemisphere associated with stronger cravings produced a larger improvement (2.3 points on a 9-point scale) compared to the opposite side (1.6 points). This kind of finding is where AI could eventually play a role: using algorithms to identify which brain areas to target for each individual patient.
Laser Acupuncture for Stimulants and Smoking
A separate approach uses low-level lasers on acupuncture points, most commonly on the ear, rather than directly on the brain. This technique replaces traditional needles with a painless beam of light aimed at specific points believed to influence the body’s stress response and reward pathways.
For methamphetamine users undergoing group therapy, a pilot study found laser acupuncture produced no adverse events and was well-tolerated even by agitated participants who would have struggled to sit through a traditional 30- to 60-minute needle acupuncture session. Laser sessions are shorter and completely non-invasive, which makes them practical for populations that are difficult to treat.
For smoking cessation, the evidence is weaker. A 2025 meta-analysis found that people receiving laser auricular acupuncture were somewhat more likely to quit than comparison groups: 46% continued smoking immediately after treatment versus 83% in control groups. At three months, 61% of the laser group was still smoking compared to 87% in controls. Those gaps look meaningful, but the differences were not statistically significant, meaning the results could be due to chance. Laser therapy for smoking shows a trend in the right direction, but the evidence isn’t strong enough to call it effective.
Where AI Fits In
Artificial intelligence is not yet directly integrated into laser addiction therapy in any clinically available system. The role AI could play is in personalization: analyzing brain imaging data to determine exactly where to aim light, adjusting intensity and session frequency based on a patient’s response, or predicting which patients are most likely to benefit. Machine learning is already used this way in other brain stimulation fields, but published research combining AI with laser therapy specifically for addiction doesn’t exist yet.
The potential is real but theoretical. Addiction varies enormously between individuals. The brain circuits involved differ based on the substance, the person’s genetics, how long they’ve been using, and what other mental health conditions are present. An AI system that could map those differences and customize a laser protocol accordingly would be a significant advance over the one-size-fits-all approach used in current studies.
What a Treatment Session Looks Like
For transcranial photobiomodulation, the experience is simple. A device is placed against or near the forehead, and near-infrared light is delivered for a set period. There are no needles, no anesthesia, and no sensation of pain. Study protocols have varied, but a typical course involves multiple sessions over several weeks. One opioid study protocol called for 12 sessions spread across four weeks, each lasting about 15 minutes.
Laser acupuncture sessions are similarly straightforward. A handheld laser is pointed at specific spots on the ear or body for a few seconds to a few minutes per point. The laser is low-power and doesn’t produce heat or discomfort.
Safety Profile
The safety record so far is clean. Across multiple studies involving both brain-directed and acupuncture-style laser therapy, participants have reported no adverse events directly attributable to the treatment. The light levels used are too low to cause tissue damage or heating. Studies have excluded people with cancer, recent stroke or heart attack, pregnancy, and active suicidal ideation, so the safety data applies to a screened population rather than everyone.
One practical safety advantage of laser acupuncture over traditional needle acupuncture is the elimination of bloodborne infection risk. People with substance use disorders have higher rates of hepatitis B, hepatitis C, and HIV, which creates real exposure risks for practitioners using needles. Laser acupuncture removes that concern entirely.
Regulatory Status and Availability
No laser device has FDA approval specifically for treating addiction. Some light therapy systems have been cleared for unrelated uses like musculoskeletal pain relief, and clinics sometimes market these devices for addiction treatment off-label. The FDA clearance that exists for light therapy devices covers things like neck and shoulder pain, not substance use disorders.
This means if you encounter a clinic offering “laser addiction treatment,” it is operating outside the boundaries of what regulators have formally evaluated. That doesn’t automatically mean it’s unsafe, but it does mean the treatment hasn’t met the evidentiary standard required for an approved indication. Insurance coverage is unlikely for an unapproved use, so patients typically pay out of pocket.
The gap between laboratory results and clinical availability remains wide. The optogenetics research that dramatically reversed cocaine addiction in rats can’t be replicated in humans with current technology. The tPBM results for opioid cravings are promising but come from small trials that need replication at larger scale. Laser acupuncture for smoking shows a possible benefit that hasn’t reached statistical significance. Each of these threads points in an encouraging direction, but none has produced the kind of robust, replicated evidence that would make laser therapy a standard addiction treatment.